With the deepening understanding of immunological mechanisms and the emergence of new approaches such as targeted therapies and personalized treatment plans, the diagnosis and treatment of glomerular diseases are undergoing a profound and critical paradigm shift. To explore the latest research findings on immune mechanisms in glomerular diseases and promote academic exchange and clinical translation of cutting-edge strategies such as targeted and personalized therapies, the Chengdu High-Tech Zone Medical Association has decided to organize a series of conferences on "New Advances in Immune Mechanisms and Treatment of Glomerular Diseases" from December 2025 to January 2026, adopting a hybrid format combining online and offline participation.

The conferences aim to keep pace with the rapid advancements in basic research and clinical treatment in this field, creating a high-quality platform for consensus-building and translational progress. Through sustained and in-depth interdisciplinary dialogue, the conferences seek to facilitate the effective integration of cutting-edge scientific discoveries and clinical practice. This collaborative effort will explore more precise and effective diagnostic and treatment strategies, ultimately benefiting patients and elevating China’s overall innovation and clinical expertise in this field.